Medtronic CEO to retire & more: 13 device company notes

Written by Eric Oliver | September 04, 2019 | Print  |

Here are 13 key notes on spine and orthopedic device companies:

Medtronic Chairman and CEO Omar Ishrak plans to retire as CEO at the end of the 2020 fiscal year.

Stryker acquired a point-of-care imaging technology company for up to $550 million on Sept. 4.

The first spine surgery procedures using MiRus' MoRe superalloy have recently been completed.

The FDA granted Kuros Biosciences approval to evaluate Fibrin-PTH in a Phase 2a clinical trial.

The FDA provided 510(k) clearance for 4WEB Medical's Cervical Spine Truss System-Stand Alone interbody fusion device.

Ozop Surgical agreed to an exclusive licensing deal for implants developed by Spinal Resources.

NuVasive appointed NFL hall of famer Jerome Bettis as a brand ambassador.

The FDA approved Eli Lilly's monoclonal antibody Taltz for the treatment of active ankylosing spondylitis in adults.

The FDA granted ApiFix, a motion-preservation scoliosis correction company, the humanitarian device exemption for its minimally invasive deformity correction system.

The Delaware Chancery Court entered summary judgment in favor of Alphatec and its chairman and CEO Pat Miles after Mr. Miles' former employer, NuVasive, accused him of violating a noncompete agreement.

DiscGenics received FDA Fast Track designation for its investigational cell therapy for the reduction in pain and disability linked with degenerative disc disease.

Fuse Medical launched Sterizo, a new total knee replacement system.

SurGenTec received FDA clearance for its Alara neuro access needle kit.

More articles on biologics: 
NASS unveils '20 Under 40' spine surgeons for 2019
Dr. Death to hit TV screens: A timeline of the former neurosurgeon's case
How spine, neurosurgery departments are evolving — key thoughts from 4 leaders

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months